3 terminated, 2 completed, 1 recruiting. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 3, Completed 2, Recruiting 1 |
| Phase 1 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow silmitasertib: new trials by email Literature Review of silmitasertib trials Research Report on silmitasertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors Silmitasertib, Irinotecan, Temozolomide - Neuroblastoma, Ewing Sarcoma | Phase 1 / Phase 2 | Recruiting | Milton S. Hershey Medical Center | 104 | 2024-10-30 | 2026-11-12 |
| CX-4945 in Viral Community Acquired Pneumonia CX-4945 (SARS-CoV-2 domain), Placebo (SARS-CoV-2 domain), CX-4945 (Influenza virus domain) - Community-acquired Pneumonia, SARS-CoV-2 -Associated Pneumonia | Phase 2 | Terminated | Senhwa Biosciences, Inc. | 45 | 2024-03-20 | 2026-01-08 |
| Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) Silmitasertib - Coronavirus | Phase 2 | Terminated | University of Arizona | 31 | 2021-01-21 | 2023-11-07 |
| Evaluating Safety, Pharmacokinetics and Clinical Benefit of Silmitasertib (CX-4945) in Subjects With Moderate COVID-19 Silmitasertib, SOC - Covid19 | Phase 2 | Completed | Senhwa Biosciences, Inc. | 20 | 2020-11-30 | 2025-01-16 |
| Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery CX 4945 - Medulloblastoma, Childhood, Medulloblastoma Recurrent | Phase 1 / Phase 2 | Terminated | Pediatric Brain Tumor Consortium | 21 | 2019-07-25 | 2026-10-19 |
| Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma CX-4945, Cisplatin, Gemcitabine - Cholangiocarcinoma | Phase 1 / Phase 2 | Completed | Senhwa Biosciences, Inc. | 127 | 2014-06-01 | 2021-10-22 |
COVID-19 (3) · Bile Duct Neoplasms (1) · Biliary Tract Neoplasms (1) · Cholangiocarcinoma (1) · Community-Acquired Pneumonia (1) · Coronavirus Infections (1) · Influenza, Human (1) · Liposarcoma (1) · Medulloblastoma (1) · Microphthalmia, Isolated, with Coloboma 5 (1) · Neuroblastoma (1) · Osteosarcoma (1) · Rhabdomyosarcoma (1) · Sarcoma, Ewing (1)
Senhwa Biosciences, Inc. (3) · Milton S. Hershey Medical Center (1) · Pediatric Brain Tumor Consortium (1) · University of Arizona (1)
United States (5) · Taiwan (2) · Canada (1) · South Korea (1)
Chandrika Behura, MD (1) · Chris P. Recknor, MD (1) · Jason Huang, M.D. (1) · Mitesh Borad, M.D. (1) · Ralph Salloum, MD (1)
UM1CA081457 (1)